Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoclasts: what do they do and how do they do it?

Steven L Teitelbaum1

  • 1Department of Pathology and Immunology, Washington University School of Medicine, Campus Box 8118, 660 South Euclid Ave., St. Louis, MO 63110, USA. teitelbs@wustl.edu

The American Journal of Pathology
|January 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activation of the noncanonical inflammasome-GSDMD pathway triggers pyroptosis in bone marrow and promotes periosteal bone formation.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025
Same author

Activation of the noncanonical inflammasome-GSDMD pathway triggers pyroptosis in bone marrow and promotes periosteal bone formation.

bioRxiv : the preprint server for biology·2025
Same author

Hydroxyapatite microspheres induce durable pleurodesis and are rapidly cleared by pleural osteoclasts.

JCI insight·2025
Same author

Depletion of marrow adipo-CAR cells in mice enhances bone formation by activating bone morphogenetic protein receptor (BMPR) in pre-osteoblasts.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025
Same author

Pulmonary osteoclast-like cells in silica induced pulmonary fibrosis.

Science advances·2024
Same author

A bone to pick-cellular and molecular mechanisms of bone pain in sickle cell disease.

Frontiers in pain research (Lausanne, Switzerland)·2024
Same journal

Lxrα Deficiency Primes Retinal Degeneration, but Aging Drives Disease Severity.

The American journal of pathology·2026
Same journal

MYC is functionally required in both normal and neoplastic Meibomian glands.

The American journal of pathology·2026
Same journal

Fumaric Acid Esters as Modulators of Ocular Inflammation and Angiogenesis.

The American journal of pathology·2026
Same journal

Krüppel-like factor 5 inhibition rescues cavernous nerve-injured erectile dysfunction by preventing phenotypic switch and mitochondrial dysfunction-dependent apoptosis in corpus cavernosum smooth muscle cells.

The American journal of pathology·2026
Same journal

APOE4 as a Modifier of Chemotherapy Response.

The American journal of pathology·2026
Same journal

Spatial Pathobiology in the Omics Era: Transforming Modern Pathology.

The American journal of pathology·2026
See all related articles

Osteoporosis, a bone disease, involves increased osteoclast activity. Targeting osteoclast differentiation and function offers potential therapies for this prevalent skeletal condition.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • Osteoporosis prevalence increases with aging populations, highlighting the need for therapeutic targets.
  • Osteoclast activity, a key factor in bone resorption, is central to osteoporosis pathogenesis.
  • Understanding osteoclast differentiation and function is crucial for developing anti-osteoporosis treatments.

Discussion:

  • Osteoclast differentiation is regulated by cytokines like RANK ligand and M-CSF, with TNF-alpha also playing a role in inflammatory bone loss.
  • Mature osteoclasts utilize alphavbeta3 integrin to adhere to bone, triggering intracellular signals that organize the cytoskeleton.
  • Bone degradation involves creating an acidic microenvironment for mineral mobilization and cathepsin K for organic matrix breakdown.

Key Insights:

Related Experiment Videos

  • Osteoclasts, derived from monocyte/macrophage precursors, are critical for bone resorption.
  • Specific molecular pathways, including cytokine signaling and integrin-mediated adhesion, govern osteoclast activity.
  • Key molecules like RANK ligand, M-CSF, TNF-alpha, alphavbeta3 integrin, and cathepsin K are involved in osteoclast function.

Outlook:

  • Identifying and targeting molecules involved in osteoclast differentiation and function presents a promising therapeutic strategy for osteoporosis.
  • Further research into the molecular mechanisms of osteoclast biology can lead to novel drug development.
  • Interventions aimed at modulating osteoclast activity hold potential for managing degenerative skeletal diseases.